These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 25689073)

  • 1. Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
    Hola K; Markova Z; Zoppellaro G; Tucek J; Zboril R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1162-76. PubMed ID: 25689073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
    Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
    Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface engineering of magnetic iron oxide nanoparticles by polymer grafting: synthesis progress and biomedical applications.
    Hou Z; Liu Y; Xu J; Zhu J
    Nanoscale; 2020 Jul; 12(28):14957-14975. PubMed ID: 32648868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in surface chemistry strategies for the fabrication of functional iron oxide based magnetic nanoparticles.
    Turcheniuk K; Tarasevych AV; Kukhar VP; Boukherroub R; Szunerits S
    Nanoscale; 2013 Nov; 5(22):10729-52. PubMed ID: 24091568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
    Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
    Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications.
    Amstad E; Textor M; Reimhult E
    Nanoscale; 2011 Jul; 3(7):2819-43. PubMed ID: 21629911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
    Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
    Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic iron oxide nanoparticles for biomedical applications.
    Laurent S; Bridot JL; Elst LV; Muller RN
    Future Med Chem; 2010 Mar; 2(3):427-49. PubMed ID: 21426176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic Mineralization of Tumor Targeted Ferromagnetic Iron Oxide Nanoparticles Used for Media of Magnetic Hyperthermia.
    Xie S; Yin G; Pu X; Hu Y; Huang Z; Liao X; Yao Y; Chen X
    Curr Drug Deliv; 2017; 14(3):349-356. PubMed ID: 27009894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphonate-anchored monolayers for antibody binding to magnetic nanoparticles.
    Benbenishty-Shamir H; Gilert R; Gotman I; Gutmanas EY; Sukenik CN
    Langmuir; 2011 Oct; 27(19):12082-9. PubMed ID: 21863873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications and potential toxicity of magnetic iron oxide nanoparticles.
    Liu G; Gao J; Ai H; Chen X
    Small; 2013 May; 9(9-10):1533-45. PubMed ID: 23019129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
    Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
    Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.
    Xie W; Guo Z; Gao F; Gao Q; Wang D; Liaw BS; Cai Q; Sun X; Wang X; Zhao L
    Theranostics; 2018; 8(12):3284-3307. PubMed ID: 29930730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron Oxide Nanoparticles: Physicochemical Characteristics and Historical Developments to Commercialization for Potential Technological Applications.
    Etemadi H; Buchanan JK; Kandile NG; Plieger PG
    ACS Biomater Sci Eng; 2021 Dec; 7(12):5432-5450. PubMed ID: 34786932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications.
    Frimpong RA; Hilt JZ
    Nanomedicine (Lond); 2010 Nov; 5(9):1401-14. PubMed ID: 21128722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Perspectives on Biomedical Applications of Iron Oxide Nanoparticles.
    Magro M; Baratella D; Bonaiuto E; de A Roger J; Vianello F
    Curr Med Chem; 2018 Feb; 25(4):540-555. PubMed ID: 28618993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
    Lin J; Li Y; Li Y; Wu H; Yu F; Zhou S; Xie L; Luo F; Lin C; Hou Z
    ACS Appl Mater Interfaces; 2015 Jun; 7(22):11908-20. PubMed ID: 25978458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of water-based ferrofluids as contrast agents for magnetic resonance imaging.
    Casula MF; Corrias A; Arosio P; Lascialfari A; Sen T; Floris P; Bruce IJ
    J Colloid Interface Sci; 2011 May; 357(1):50-5. PubMed ID: 21345440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent.
    Nitin N; LaConte LE; Zurkiya O; Hu X; Bao G
    J Biol Inorg Chem; 2004 Sep; 9(6):706-12. PubMed ID: 15232722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.